Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sirolimus-eluting coronary stent - Micell Technologies

Next Previous
Search
Drug Profile

Sirolimus-eluting coronary stent - Micell Technologies

Alternative Names: MiStent; MiStent SES

Latest Information Update: 30 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Micell Technologies
  • Developer Micell Technologies; Stentys
  • Class Anti-infectives; Anti-inflammatories; Antiepileptic drugs; Antifungals; Antineoplastics; Cardiovascular therapies; Eye disorder therapies; Lactones; Macrolides; Nootropics; Polyenes; Pyridines; Skin disorder therapies
  • Mechanism of Action Immunosuppressants; Methylmalonyl CoA mutase stimulants; MTOR protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery restenosis
  • Phase III Coronary disorders

Most Recent Events

  • 27 Sep 2021 Sirolimus-eluting coronary stent is still in phase III DESSOLVE-C trial for Coronary disorder (In adults, In the elderly) in China (NCT02448524)
  • 18 Feb 2019 Sirolimus-eluting coronary stent is still in phase III DESSOLVE-C trial for Coronary disorder (In adults, In the elderly) in China (NCT02448524)
  • 01 Aug 2016 Micell Technologies completes the DESSOLVE II phase II trial for Coronary artery restenosis prevention in Belgium, France, the Netherlands, Sweden, United Kingdom and New Zealand (NCT01294748)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top